Impax Labs kept by Smith Barney at hold

Impax Laboratories Inc. was maintained by Smith Barney Citigroup analyst Andrew Swanson at a hold rating with a price target on the stock of $15 per share following the company's notification that the stock will be delisted from the Nasdaq and begin trading on pink sheets Monday under the ticker IPXL, due to its ongoing failure to file financial reports with the SEC. Impax Labs shares Friday sank $3.83, or 27.14%, to close at $10.28 on volume of 13,480,585 shares versus the three-month running average of 655,402 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.